Immunotherapy of Cancer Forum – ITOC

ITOC-LogoThe Immunotherapy of Cancer (ITOC) Forum addresses regulatory issues concerning new immunotherapies, hosts workshops, provides education around immunotherapy, and hosts the annual Immunotherapy of Cancer  Conference (ITOC).

  • The conference, which is the largest immunotherapy meeting in Europe, includes plenary symposium, poster sessions, satellite symposium and an exhibition. The meeting is accredited by the European Council for Continuing Medical Education (EACCME). View more about the next annual conference on http://itoc-conference.eu/
  • The ITOC Education workshop on cancer immunotherapy presented by leading faculty in cancer immunotherapy, is designed for clinical oncologists, clinical scientists from industry, regulatory scientists, nurses, patient advocates, students and the entire medical team involved in treating cancer patients with immunotherapy. The course provides a greater understanding of cancer immunotherapies, their therapeutic effectiveness and the appropriate selection and management of cancer patients. The format will be a one-day programme, hosted at cancer meetings throughout the year. Discover more and join one course on http://itoc-conference.eu/itoc-education
  • The forum workshops on immunotherapies:
    • the EMA-CDDF Joint Meeting on the ‘Challenges for the Approval of Anti-Cancer Immunotherapeutic Drugs’ (London, UK – 4 & 5 February 2016)
    • the CDDF workshop on ‘Immuno Biomarker Development in the Peripheral Blood’ (Vienna, Austria – 7 & 8 December 2015)

Read more about the ITOC Forum website: http://itoc-conference.eu/